260 related articles for article (PubMed ID: 8360594)
1. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
Alleva DG; Askew D; Burger CJ; Elgert KD
J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
[TBL] [Abstract][Full Text] [Related]
2. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
Alleva DG; Burger CJ; Elgert KD
Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
[TBL] [Abstract][Full Text] [Related]
7. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
Alleva DG; Burger CJ; Elgert KD
Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
[TBL] [Abstract][Full Text] [Related]
8. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
Alleva DG; Elgert KD
Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
Denbow CJ; Conroy JM; Elgert KD
Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
[TBL] [Abstract][Full Text] [Related]
10. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
Alleva DG; Walker TM; Elgert KD
J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
Askew D; Burger CJ; Elgert KD
Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
[TBL] [Abstract][Full Text] [Related]
12. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced variations in a high molecular weight inhibitory monokine.
Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.
Malick AP; Elgert KD; Garner RE; Adkinson NF
J Leukoc Biol; 1987 Dec; 42(6):673-81. PubMed ID: 2960767
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
[TBL] [Abstract][Full Text] [Related]
16. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
[TBL] [Abstract][Full Text] [Related]
18. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
19. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity.
Garner RE; Malick AP; Yurochko AD; Elgert KD
Cell Immunol; 1987 Sep; 108(2):255-68. PubMed ID: 2957065
[TBL] [Abstract][Full Text] [Related]
20. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.
Alleva DG; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1994 Nov; 23(6-7):457-72. PubMed ID: 7851963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
